VIM and breast carcinoma: Moreover, the combination of HON and TAM reduced the expression of the potential target genes SOX2, RET, ERBB4, and FN1, as well as the neighboring genes HES1, VIM, and PCNA. This proves the potential of HON to overcome the resistance of breast cancer cells to TAM by inhibiting the expression of these target genes.